QuantRx(R) Announces FDA 510(k) Clearance For Its RapidSense(R) Methamphetamine Test (Medical News Today)
QuantRx Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, announced that the U.S. Food and Drug Administration (FDA) has granted the Company 510(k) clearance on its RapidSense drugs-of-abuse (DOA) Methamphetamine test.

Sun Pharmaceutical receives FDA approvals for 4 generics (News-Medical-Net)
Sun Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from U.S. FDA for several Abbreviated New Drug Applications (ANDA).

Sun Pharma receives US FDA approvals for 4 generic products (PharmaBiz)
The Mumbai-based Sun Pharmaceutical Industries Ltd has received Abbreviated New Drug Applications (ANDA) approval for four of its products from the US FDA.